Evidence map›Paper›PMID 20663865›Full record

ArticleThe Journal of biological chemistry2010

The Necdin-Wnt pathway causes epigenetic peroxisome proliferator-activated receptor gamma repression in hepatic stellate cells.

Nian-Ling Zhu, Jiaohong Wang, Hidekazu Tsukamoto

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Frontiers in cardiovascular medicine · 2022
    Review
  3. Necdin: A purposive integrator of molecular interaction networks for mammalian neuron vitality.Genes to cells : devoted to molecular & cellular mechanisms · 2021
    Review
  4. Article
  5. Metabolic Coordination of Pericyte Phenotypes: Therapeutic Implications.Frontiers in cell and developmental biology · 2020
    Review
  6. Article
  7. Article
  8. Wnt-β-catenin signalling in liver development, health and disease.Nature reviews. Gastroenterology & hepatology · 2019
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Morphogen-related therapeutic targets for liver fibrosis.Clinics and research in hepatology and gastroenterology · 2015
    Review
  14. Metabolic reprogramming and cell fate regulation in alcoholic liver disease.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2015
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nian-Ling ZhuDepartment of Pathology, Southern California Research Center for ALPD and Cirrhosis, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.
Jiaohong Wang
Hidekazu Tsukamoto
VA Greater Los Angeles Healthcare System · US

Funding

The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ANNA S. GUKOVSKAYA · 1999 to 2026
$45.8M
NON-PARENCHYMAL LIVER CELL CORER24AA012885 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TSUKAMOTO, HIDEKAZU · 2001 to 2025
$8.1M
Epigenetic Regulation of Alcoholic Liver FibrosisU01AA018663 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KISSELEVA, TATIANA, MANN, DEREK · 2010 to 2019
$3.7M
Epigenetic mechanism of HSC transdifferentiation in alcoholic liver fibrosisR21AA016682 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TSUKAMOTO, HIDEKAZU · 2006 to 2007
$402k
NIAAA NIH HHS P50 AA011999NIAAA NIH HHS P50AA011999NIAAA NIH HHS R21 AA016682NIAAA NIH HHS R21AA016682NIAAA NIH HHS R24 AA012885NIAAA NIH HHS R24AA012885NIAAA NIH HHS U01 AA018663
6 · The paper itself

Abstract

Hepatic stellate cells (HSCs), vitamin A-storing liver pericytes, undergo myofibroblastic trans-differentiation or "activation" to participate in liver wound healing. This cellular process involves loss of regulation by adipogenic transcription factors such as peroxisome proliferator-activated receptor γ (PPARγ). Necdin, a melanoma antigen family protein, promotes neuronal and myogenic differentiation while inhibiting adipogenesis. The present study demonstrates that necdin is selectively expressed in HSCs among different liver cell types and induced during their activation in vitro and in vivo. Silencing of necdin with adenovirally expressed shRNA, reverses activated HSCs to quiescent cells in a manner dependent on PPARγ and suppressed canonical Wnt signaling. Promoter analysis, site-directed mutagenesis, and chromatin immunoprecipitation demonstrate that Wnt10b, a canonical Wnt induced in activated HSCs, is a direct target of necdin. Necdin silencing abrogates three epigenetic signatures implicated in repression of PPARγ: increased MeCP2 (methyl CpG binding protein 2) and HP-1α co-repressor recruitments to Pparγ promoter and enhanced H3K27 dimethylation at the exon 5 locus, again in a manner dependent on suppressed canonical Wnt. These epigenetic effects are reproduced by antagonism of canonical Wnt signaling with Dikkopf-1. Our results demonstrate a novel necdin-Wnt pathway, which serves to mediate antiadipogenic HSC trans-differentiation via epigenetic repression of PPARγ.

Indexed as

Signal TransductionAdipogenesisAnimalsChemical and Drug Induced Liver InjuryEpigenesis, GeneticGene SilencingHepatic Stellate CellsHistonesIntercellular Signaling Peptides and ProteinsMaleMethyl-CpG-Binding Protein 2Nerve Tissue ProteinsNuclear ProteinsPPAR gammaRatsRats, WistarDkk1 protein, ratHistonesIntercellular Signaling Peptides and ProteinsMecp2 protein, ratMethyl-CpG-Binding Protein 2necdinNerve Tissue ProteinsNuclear ProteinsPPAR gammaWnt10b protein, ratWnt Proteins

Identifiers

PMID20663865
PMCPMC2945539
OpenAlexW2055125978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.